US company poised to start COVID-19 vaccine safety test
- 07-Apr-2020
Inovio plans to inject its first volunteer test subject with the INO-4800 DNA vaccine candidate it has developed, following promising results from preclinical studies performed on animals that did indicate increased immune response.